Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for SYNTHESE VON OMECAMTIV MECARBIL
Details for 2021174262
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2021174262
Title / Product Name
SYNTHESE VON OMECAMTIV MECARBIL
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2021174262
EP Publication Number
3925950
E-Number
1608419
Language
EN
PCT Number
Publication Date
22.12.2021 A
06.09.2023 B1
Registration Date
06.09.2023
AT Publication Date
15.09.2023
Application Date
29.06.2018
Registration Number
-
Priorities
30.06.2017
US
201762527174 P
30.04.2018
US
201862664363 P
IPC
C07D 213/75 20060101AFI20211104BHEP
Maximum Duration of Protection
29.06.2038
Owner
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
US
Representative
No representatives present
Inventor
CAILLE, Sebastien
Moorpark
US
QUASDORF, Kyle
Thousand Oaks
US
ROOSEN, Philipp
Thousand Oaks
US
SHI, Xianqing
Newbury Park
US
COSBIE, Andrew
Ventura
US
WANG, Fang
Simi Valley
US
WU, Zufan
Walnut
US
NEERGUNDA, Archana
Simi Valley
US
QUAN, Peter Bin
Woodland
US
GUAN, Lianxiu
Camarillo
US